In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events - KIVIRID

In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events

Authors: Ying X. Gue, Gregory Y.H. Lip

Published: 2021-04-05

DOI: 10.7326/acpj202104200-043

Source: Full article

Abstract

No abstract found.